Lv3
220 积分 2023-02-21 加入
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
9个月前
已完结
Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation
10个月前
已关闭
Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer
10个月前
已完结
Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy
10个月前
已完结
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
10个月前
已完结
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study
10个月前
已完结
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
11个月前
已完结
The state of the art of EGFR exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectives
11个月前
已关闭
Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases
11个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
11个月前
已完结
皖公网安备34019202002308
